Drug · DIN 02312751
PRO-RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 9, 2008; first marketed July 9, 2008.
- Drug Identification Number (DIN)
- 02312751
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 4.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 5, 2016: NOC 18727Supplement to an Abbreviated New Drug Submission (SANDS) · Update to product monograph to be in line with crp
- July 2, 2008: NOC 9654Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “pro-risperidone”. A notice may cover another product or only some lots: read it to see what it covers.
- PRO-Risperidone 0.5 mgOctober 29, 2012 · Drugs · Dosage · Type II
Other DINs named PRO-RISPERIDONE
- DIN 02312700 · Marketed
- DIN 02312719 · Marketed
- DIN 02312727 · Marketed
- DIN 02312735 · Marketed
- DIN 02312743 · Marketed